gip and glp 1 receptor agonist Potential Use of GLP-1 GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? GLP-1 agonists approved for clinical

Comparing GLP-1 Medications: Key Differences and Considerations Choosing among the various GLP 1 options requires understanding key differences in dosing frequency, efficacy and practical considerations around cost and access

This study established time-course, dose-response, and covariate models for each drug

Addressing Metabolic Dysfunction as an Independent Cancer Risk Factor Accumulating evidence positions metabolic dysfunction characterised by insulin resistance, hepatic steatosis, dyslipidaemia, and visceral adiposity as a more powerful and proximate predictor of cancer risk than elevated body weight alone

Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy